Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: Analysis by immunohistochemistry and an in situ DNA nick end-labelling method

Journal of Oral Pathology and Medicine

Volumn 26, Issue 9, 1997, Pages 419-425

  Kumamoto, Hiroyuki ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Ameloblastoma; Apoptosis; Malignant ameloblastoma; Odontogenic epithelium

Indexed keywords

EID: 0031259681     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1997.tb00242.x     Document Type: Article

References (51)

1. KRAMER IRH, PINDBORG JJ, SHEAR M. The WHO histological typing of odontogenic tumours: a commentary on the second edition. Cancer 1992; 70: 2988-94.
2. SHEAR M. Developmental odontogenic cysts: an update. J Oral Pathol Med 1994; 23: 1-11.
3. KUMAMOTO H, MIYAZAWA M, OOYA K. Characterization of novel monoclonal antibodies raised against formalin-fixed, paraffin-embedded human ameloblastoma. J Oral Pathol Med 1996; 25: 484-90.
4. NASU M, ISHIKAWA G. Ameloblastoma: light and electron microscopic study. Virchows Arch Pathol Anat 1983; 399: 163-75.
5. KRAMER IRH, PINDBORG JJ, SHEAR M. WHO histological typing of odontogenic tumours. Berlin: Springer-Verlag, 1992: 11-4.
6. KRAMER IRH, PINDBORG JJ, SHEAR M. WHO histological typing of odontogenic tumours. Berlin: Springer-Verlag, 1992: 25.
7. MYOKEN Y, MYOKEN Y, OKAMOTO T, SATO JD, TAKADA K. Immunohistochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in cultured human ameloblastoma epithelial cells and ameloblastoma tissues. J Oral Pathol Med 1995; 24: 387-92.
8. SLOOTWEG PJ. P53 protein and Ki-67 reactivity in epithelial odontogenic lesions: an immunohistochemical study. J Oral Pathol Med 1995; 24: 393-7.
9. KERR JFR. Shrinkage necrosis: a distinct mode of cellular death. J Pathol 1971; 105: 13-20.
10. KERR JFR, WYLLIE AH, CURRIE AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
11. CARSON DA, RIBEIRO JM. Apoptosis and disease. Lancet 1993; 341: 1251-4.
12. MAJNO G, JORIS I. Apoptosis, oncosis and necrosis: an overview of cell death. Am J Pathol 1995; 146: 3-15.
13. WYLLIE AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-6.
14. WYLLIE AH, KERR JFR, CURRIE AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
15. YONEHARA S, ISHII A, YONEHARA M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down-regulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169: 1747-56.
16. SUDA T, TAKAHASHI T, GOLSTEIN P, NAGATA S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-78.
17. YONISH-ROUACH E, RESNITZKY D, LOTEM J, SACHS L, KIMCHI A, OREN M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345-7.
18. EVAN GI, WYLLIE AH, GILBERT CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-28.
19. SMEYNE RJ, VENDRELL M, HAYWARD M, et al. Continuous c-fos expression precedes programmed cell death in vivo. Nature 1993; 363: 166-9.
20. y antigen expression is correlated with apoptosis (programmed cell death). Glycobiology 1993; 3: 381-90.
21. VAUX DL, CORY S, ADAMS JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-2.
22. HOCKENBERY D, NUÑES G, MILLIMAN C, SCHREIBER RD, KORSMEYER SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
23. GAVRIELI Y, SHERMAN Y, BEN-SASSON SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
24. MORI C, NAKAMURA N, OKAMOTO Y, OSAWA M, SHIOTA K. Cytochemical identification of programmed cell death in the fusion fetal mouse palate by specific labelling of DNA fragmentation. Anat Embryol 1994; 190: 21-8.
25. SLOOTWEG PJ, DE VEGER RA. Immunohistochemical demonstration of bcl-2 protein in human tooth germs. Arch Oral Biol 1994; 39: 545-50.
26. NISHIKAWA S, SASAKI F. DNA localization in nuclear fragments of apoptotic ameloblasts using anti-DNA immunoelectron microscopy: programmed cell death of ameloblasts. Histochem Cell Biol 1995; 104: 151-9.
27. SHIBATA S, SUZUKI S, TENGAN T, YAMASHITA Y. A histochemical study of apoptosis in the reduced ameloblasts of erupting mouse molars. Arch Oral Biol 1995; 40: 677-80.
28. ABIKO Y, KANNO H, ARAI J, NISHIMURA M, SAITOH M, KAKU T. Apoptotic cell death at tooth eruption in rat molar observed by in situ labelling of nuclear DNA fragmentation. Jpn J Oral Biol 1995; 37: 488-92.
29. KEY G, BECHER MHG, BARON B, et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993; 68: 629-36.
30. BÁNKFALVI À, NAVABI H, BIER B, BÖCKER W, JASANI B, SCHMID KW. Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol 1994; 174: 223-8.
31. PIFFKÓ J, BÁNKFALVI À, ÖFNER D, JOOS U, BÖCKER W, SCHMID KW. Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval. J Pathol 1995; 176: 69-75.
32. TERADA T, NAKANUMA Y. Detection of apoptosis and expression of apoptosis-related proteins during human intrahepatic bile duct development. Am J Pathol 1995; 146: 67-74.
33. KRAMER IRH, PINDBORG JJ, SHEAR M. WHO histological typing of odontogenic tumours. Berlin: Springer-Verlag, 1992: 1-5.
34. NAKAGAWA S, SHIRAISHI T, KIHARA S, TABUCHI K. Detection of DNA strand breaks associated with apoptosis in human brain tumors. Virchows Arch Pathol Anat 1995; 427: 175-9.
35. TSUJIMOTO Y, COSSMAN J, JAFFE E, CROCE CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-3.
36. LE BRUN DP, WARNKE RA, CLEARY ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993; 142: 743-53.
37. PEZZELLA F, TSE AGD, CORDELL JL, PULFOLD KAF, GATTER KC, MASON DY. Expression of the bcl-2 protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990; 137: 225-32.
38. JOENSUU H, PYLKKÄNEN L, TOIKKANEN S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 1994; 145: 1191-8.
39. BRONNER MP, CULIN C, REED JC, FURTH EE. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 1995; 146: 20-6.
40. SINICROPE FA, RUAN SB, CLEARY KR, STEPHENS LC, LEE JJ, LEVIN B. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995; 55: 237-41.
41. MILLER C, MOHANDAS T, WOLF D, PROKOCIMER M, ROTTER V, KOEFFLER HP. Human p53 gene localized to short arm of chromosome 17. Nature 1986; 319: 783-9.
42. DONOVA M, GIORDANO M, MAZZINI G, RICCARDI A. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leukemia Res 1990; 14: 417-22.
43. FINLAY CA, HINDS PW, LEVINE AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083-93.
44. SHIAO Y-H, RUGGE M, CORREA P, LEHMANN HP, SCHEER WD. P53 alteration in gastric precancerous lesions. Am J Pathol 1994; 144: 511-7.
45. PIFFKÓ J, BÁNKFALVI À, ÖFNER D, et al. Expression of p53 protein in oral squamous cell carcinomas and adjacent non-tumorous mucosa of the floor of the mouth. J Oral Pathol Med 1995; 24: 337-42.
46. y and p53) in human cholangiocarcinomas and hepatocellular carcinomas. Pathol Int 1996; 46: 764-70.
47. CLARKE AR, PURDIE CA, HARRISON DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849-52.
48. x blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res 1989; 49: 745-52
49. y blood group-related antigens in human malignant, premalignant, and nonmalignant colonic tissues. Cancer Res 1986; 46: 5985-92.
50. NAKAMURA T, SAKAI T, NARIYA S. Cell death in colorectal polyps as evaluated by in situ 3′-tailing reaction and its relationship to BCL-2 expression. Pathol Int 1995; 45: 721-8.
51. IKENAGA M, TAKANO Y, SAEGUSA M, et al. Apoptosis of colon cancers assessed by in situ DNA nick end-labeling method. Pathol Int 1996; 46: 33-7.